bempikibart (ADX-914)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)NCT06018428QTTBPhase 2Active not recruiting2026-06Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.